-
1
-
-
0023891864
-
Insights into the pathogenesis of acute ischemic syndromes
-
Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988; 77: 1213-1220
-
(1988)
Circulation
, vol.77
, pp. 1213-1220
-
-
Fuster, V.1
Badimon, L.2
Cohen, M.3
Ambrose, J.A.4
Badimon, J.J.5
Chesebro, J.6
-
2
-
-
0021847311
-
Plaque fissuring: The cause of acute myocardial infarction, sudden ischemic death and crescendo angina
-
Davies MJ, Thomas A. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J 1985; 53: 363-373
-
(1985)
Br Heart J
, vol.53
, pp. 363-373
-
-
Davies, M.J.1
Thomas, A.2
-
3
-
-
0022375287
-
Aspirin, sulfinpyrazone, or both in unstable angina
-
Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985; 313: 1369-1375
-
(1985)
N Engl J Med
, vol.313
, pp. 1369-1375
-
-
Cairns, J.A.1
Gent, M.2
Singer, J.3
-
4
-
-
0023754429
-
Aspirin, heparin or both to treat unstable angina
-
Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin or both to treat unstable angina. N Engl J Med 1988; 319: 1105-1111
-
(1988)
N Engl J Med
, vol.319
, pp. 1105-1111
-
-
Theroux, P.1
Ouimet, H.2
McCans, J.3
-
5
-
-
0025090942
-
Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
-
The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-830
-
(1990)
Lancet
, vol.336
, pp. 827-830
-
-
-
6
-
-
0027525087
-
Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina
-
Theroux P, Waters D, Qui S, et al. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993; 88: 2045-2048
-
(1993)
Circulation
, vol.88
, pp. 2045-2048
-
-
Theroux, P.1
Waters, D.2
Qui, S.3
-
7
-
-
0005851710
-
Heparin variability and resistance: Comparisons with a direct thrombin inhibitor
-
Maraganore JM, Bourdon P, Adelman B, Cannon CP, Theroux P. Heparin variability and resistance: comparisons with a direct thrombin inhibitor. Circulation 1992; 86(suppl I): I-386
-
(1992)
Circulation
, vol.86
, Issue.1 SUPPL.
-
-
Maraganore, J.M.1
Bourdon, P.2
Adelman, B.3
Cannon, C.P.4
Theroux, P.5
-
8
-
-
0026434005
-
Heparin
-
Hirsh J. Heparin. N Engl J Med 1991; 324: 1565-1574
-
(1991)
N Engl J Med
, vol.324
, pp. 1565-1574
-
-
Hirsh, J.1
-
9
-
-
0026593425
-
Low molecular weight heparin
-
Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1-17
-
(1992)
Blood
, vol.79
, pp. 1-17
-
-
Hirsh, J.1
Levine, M.N.2
-
10
-
-
0022447390
-
Low molecular weight heparin. Is small beaufiful?
-
Salzman EW. Low molecular weight heparin. Is small beaufiful? N Engl J Med 1986; 315: 957-959
-
(1986)
N Engl J Med
, vol.315
, pp. 957-959
-
-
Salzman, E.W.1
-
11
-
-
0027213684
-
Comparison of efficacy of low molecular weight heparin to unfractionated heparin in presence of activated platelets in healthy subjects
-
Melandri G, Semprini F, Cervi V. Comparison of efficacy of low molecular weight heparin to unfractionated heparin in presence of activated platelets in healthy subjects. Am J Cardiol 1993; 72: 450-454
-
(1993)
Am J Cardiol
, vol.72
, pp. 450-454
-
-
Melandri, G.1
Semprini, F.2
Cervi, V.3
-
12
-
-
0020528647
-
Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina
-
Lewis DH, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309: 396-403
-
(1983)
N Engl J Med
, vol.309
, pp. 396-403
-
-
Lewis, D.H.1
Davis, J.W.2
Archibald, D.G.3
-
13
-
-
0019432150
-
Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome
-
Tedford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet 1981; 1: 1225-1228
-
(1981)
Lancet
, vol.1
, pp. 1225-1228
-
-
Tedford, A.M.1
Wilson, C.2
-
14
-
-
0025348126
-
Effect of heparin, aspirin, or alteplase in reduction of myocardial ischemia in refractory unstable angina
-
Neri Serneri GG, Gensini GF, Pogessi L, et al. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischemia in refractory unstable angina. Lancet. 1990; 335: 615-618
-
(1990)
Lancet
, vol.335
, pp. 615-618
-
-
Neri Serneri, G.G.1
Gensini, G.F.2
Pogessi, L.3
-
15
-
-
0026736119
-
Reactivation of unstable angina following discontinuation of heparin
-
Theroux P, Waters D, Lam J, et al. Reactivation of unstable angina following discontinuation of heparin. N Engl J Med 1992; 327: 141-145
-
(1992)
N Engl J Med
, vol.327
, pp. 141-145
-
-
Theroux, P.1
Waters, D.2
Lam, J.3
-
16
-
-
0027279363
-
A comparison of heparin strategies after thrombolytic therapy
-
Becker RC, Corrao JM, Ball SP, Gore JM. A comparison of heparin strategies after thrombolytic therapy. Am Heart J 1993; 126: 750-752
-
(1993)
Am Heart J
, vol.126
, pp. 750-752
-
-
Becker, R.C.1
Corrao, J.M.2
Ball, S.P.3
Gore, J.M.4
-
18
-
-
0029100793
-
Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia
-
Gurfinkel EP, Manos EJ, Mejail RI, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 1995; 26: 313-318
-
(1995)
J Am Coll Cardiol
, vol.26
, pp. 313-318
-
-
Gurfinkel, E.P.1
Manos, E.J.2
Mejail, R.I.3
-
19
-
-
9044243412
-
Low-molecular weight heparin during instability in coronary artery disease
-
FRISC Study Group. Low-molecular weight heparin during instability in coronary artery disease. Lancet 1996; 347: 561-568
-
(1996)
Lancet
, vol.347
, pp. 561-568
-
-
-
20
-
-
0025855879
-
Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo
-
Sobel M, McNeill PM, Carlson PL, et al. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest 1991; 87: 1787-1793
-
(1991)
J Clin Invest
, vol.87
, pp. 1787-1793
-
-
Sobel, M.1
McNeill, P.M.2
Carlson, P.L.3
|